Clinical Trials Directory

Trials / Completed

CompletedNCT06470139

Dexamethasone for PENG Block in Total Hip Arthroplasty

Pericapsular Nerve Group (PENG) Block with Ropivacaine Vs Ropivacaine and Dexamethasone in Total Hip Arthroplasty: a Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Poznan University of Medical Sciences · Academic / Other
Sex
All
Age
65 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Effect of adding Dexamethasone to Periarticular Nerve Group Block in Patients undergoing Total Hip Arthroplasty

Detailed description

Hip arthroplasty is one of the most common orthopaedic procedures, especially in elderly patients, due to the deformation of joints. Patients may complain of severe pain due to surgical trauma and prostheses. Regional anaesthesia methods may be performed to reduce the inflammatory response, opioid consumption, and opioid-related side effects.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaine 0.2% Injectable Solution20ml 0.2% Ropivacaine + 2.0ml 0.9% NaCl
DRUGRopivacaine 0.2% Injectable Solution + 4mg Dexamethasone20ml 0.2% Ropivacaine + 4mg Dexamethasone

Timeline

Start date
2024-08-13
Primary completion
2025-01-15
Completion
2025-02-10
First posted
2024-06-24
Last updated
2025-03-24

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06470139. Inclusion in this directory is not an endorsement.

Dexamethasone for PENG Block in Total Hip Arthroplasty (NCT06470139) · Clinical Trials Directory